secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001295947-25-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q4 revenue $296.5M, adj EPS $1.32; FY25 adj EPS $4.52; FY26 outlook $4.70-4.82
--------------------------------------------------------------------------------

- Q4 revenue $296.5M (+7.0% YoY, organic +7.9%); diluted EPS $1.00 GAAP, adjusted $1.32 (vs $1.02 prior year).
- FY2025 revenue $1,137.8M (+1.1%); diluted EPS $4.29 GAAP, adjusted $4.52 (+7.4% vs $4.21 prior year).
- Free cash flow $243.3M in FY2025 (+1.6% YoY); leverage ratio reduced to 2.4x at year-end.
- Initial FY2026 outlook: organic revenue growth ~1-2%, diluted EPS $4.70-4.82, free cash flow $245M or more.
- Management guides mid-to-high single-digit EPS growth despite ~$15M tariff headwind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000014/0001295947-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594725000014/pbh-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001295947-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer